Clinical Use of Liquid Biopsy in Metastatic Breast Cancer—An ESSO‐EYSAC International Survey
LB testing is slowly becoming more popular in clinical practice, but still faces major difficulties such as high costs, and lack of reimbursement. More evidence is needed to show that individualization of treatment by utilization of LB leads to better outcome in mBC patients.
Authors
- C. Caballero (ORCID: https://orcid.org/0000-0001-7193-8141)
- Ina Suppan (ORCID: https://orcid.org/0000-0002-8934-0284)
- Pankaj Kumar Garg (ORCID: https://orcid.org/0000-0001-9760-5484)
- Ellen Heitzer (ORCID: https://orcid.org/0000-0002-8815-7859)
- Dara Lundon (ORCID: https://orcid.org/0000-0003-4425-3520)
- Andreas Brandl (ORCID: https://orcid.org/0000-0003-1990-2584)
Institutions
- Medical University of Graz (AT)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Himalayan University (IN)
- Breast International Group (BE)
- Mount Sinai Hospital (US)
- Ordensklinikum Linz Barmherzige Schwestern (AT)
- Hospital of the Brothers of St. John of God (AT)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of Surgical Oncology
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1002/jso.70045
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.94